Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.
Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Massey J, Sutton I, Withers B, Burman J, Torkildsen Ø, Bø L, Lehmann AK, Havrdova EK, Krasulova E, Trneny M, Kozak T, Macdonell R, Brown JWL, Coles A, van der Walt A, Butzkueven H, Van Wijmeersch B, Lechner-Scott J, Barnett M, Laureys G, Willekens B, Buzzard K, Skibina O, Di Gregorio M, Hodgkinson S, Ozakbas S, Meca-Lallana JE, Alroughani R, Prevost J, Foschi M, Surcinelli A, Neri S, Eichau S, McCombe P, John N, Cárdenas-Robledo S, Oh J, Sanchez-Menoyo JL, Patti F, Gerlach O, Blanco Y, Grammond P, Sharrack B, Snowden JA.
Kalincik T, et al. Among authors: meca lallana je.
Brain. 2026 Mar 5;149(3):951-962. doi: 10.1093/brain/awaf286.
Brain. 2026.
PMID: 40755195
Free article.